Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Supply of dCODE Dextramer® Reagents (HLA-A*0201 Specificity)

Active

Federal

Response Deadline08/13/2026, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves the supply of peptide-loaded dCODE Dextramer® reagents designed to target the HLA-A*0201 molecule for use in T-cell detection and immune monitoring within research settings. These reagents are critical tools for identifying and quantifying antigen-specific T cells, enabling advanced immunological studies, particularly in areas such as vaccine development, infectious disease research, and cancer immunotherapy. The reagents must meet specified purity, stability, and binding affinity standards to ensure reliable and reproducible results in laboratory applications. The solicitation is structured as a subcontract under the National Institutes of Health NIDA, part of the Department of Health and Human Services, with a North American Industry Classification System code of 325412 indicating biological product manufacturing. The opportunity was posted on August 6, 2026, with a response deadline of August 13, 2026, at 7:00 PM. While no set-aside provisions or specific place of performance details are provided, the contract requires adherence to technical specifications for reagent formulation and quality control. The procurement process is managed through the SAM.gov platform, and interested parties must submit proposals before the stated deadline to be considered for award.

General Info

Supply of peptide-loaded dCODE Dextramer® reagents for HLA-A*0201 T-cell detection in research under NIDA subcontract.

Agency

Department Of Health And Human Services → National Institutes Of Health NidaView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 6

subcontract

Response DeadlineAug 13

Submission deadline

Response Deadline

08/13/2026, 07:00:00 PM UTCin 6 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Health And Human Services → National Institutes Of Health Nida

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supply of peptide-loaded dCODE Dextramer® reagents targeting HLA-A*0201 for T-cell detection and immune monitoring in research applications.

Similar Contracts

Same NAICS industry code

Government Contracting Compliance & GSA Schedule SupportThe contract solicits the supply of biotechnology reagents through existing GSA Schedule or GWAC vehicles, requiring full compliance with the Federal Acquisition Regulation for pricing and delivery terms. All offerings must leverage pre-negotiated, FAR-compliant contractual mechanisms to ensure transparency, affordability, and efficiency in procurement by the National Institutes of Health, specifically the National Institute on Drug Abuse under the Department of Health and Human Services. The NAICS code 325412 confirms the primary focus on pharmaceutical and biological product manufacturing, indicating the need for high-purity, research-grade reagents suitable for scientific and clinical applications. Responses must be submitted by August 13, 2026, and the contract is structured as a subcontract, implying the awardee will fulfill obligations under a prime contract holder rather than directly with the government. Performance is expected to align with federal supply chain standards, though no specific place of performance or set-aside criteria are provided. Compliance with GSA Schedule or GWAC terms is mandatory, ensuring that pricing remains consistent with established federal rates and that delivery timelines meet agency operational needs. The solicitation underscores the importance of proven regulatory adherence and reliable supply chain execution to support critical biomedical research activities.

National Institutes Of Health Nida

POSTED

DEADLINE

Specialty Biotech Reagent Manufacturing (dCODE Dextramer®)The contract involves the manufacture of specialized immunology reagents based on dextramer technology, specifically customizable HLA-peptide complexes equipped with fluorescent barcoding, intended for use in research and clinical applications. These reagents are designed to enable precise detection and analysis of antigen-specific T cells, supporting advancements in immunological studies and potential therapeutic development. The production must meet stringent quality and consistency standards to ensure reliability across diverse experimental and diagnostic settings, with an emphasis on scalability and customization to accommodate varying peptide and HLA combinations. This is a subcontract under the National Institutes of Health, specifically the National Institute on Drug Abuse, part of the Department of Health and Human Services, with the NAICS code 325412 indicating biological product manufacturing. The opportunity was posted on August 6, 2026, and responses are due by August 13, 2026, with no set-aside classification specified. The place of performance and other location details are not provided, indicating flexibility in where the manufacturing may occur, though all work must comply with the technical and regulatory requirements for clinical-grade reagents. The focus is squarely on advanced biotech manufacturing capabilities, emphasizing precision, reproducibility, and compliance with industry best practices for immune monitoring tools.

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Universal 5' Gene Expression Kits

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Feature Barcode Kits for Single-Cell Analysis

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Chromium GEM-X Single Cell 5' Chip Kits

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Single-Cell Library Construction Kits

National Institutes Of Health Nida

POSTED

DEADLINE

Virus-Vectored Oral Rabies Vaccine Bait – Fishmeal Polymer FormulationThe contract pertains to the supply of fishmeal polymer-based vaccine baits with part number 128425, specifically formulated as a virus-vectored oral rabies vaccine intended for targeted wildlife species. These baits are designed to deliver rabies immunization in a palatable, durable form that supports effective distribution in野外 environments, leveraging a fishmeal polymer matrix to ensure stability and attraction for target animals. The work under this subcontract is tied to efforts led by the USDA’s APHIS-Wildlife Services division to manage and reduce the spread of rabies among wildlife populations through strategic oral vaccination campaigns. The solicitation was posted on August 6, 2026, with submissions due by September 7, 2026, at 9:00 PM. The North American Industry Classification System code 325412 indicates the work falls under pharmaceutical and biological product manufacturing, underscoring the scientific and regulatory rigor expected in production. Performance is required to occur in Concord, New Hampshire, with a ZIP code of 03301, though no specific office address or point of contact is provided. The nature of the contract as a subcontract suggests it supports a broader federal wildlife health initiative, likely underpinning national or regional rabies control programs managed by the Department of Agriculture.

POSTED

DEADLINE

in about 1 month

Virus-Vectored Oral Rabies Vaccine Bait – Sachet FormulationThe contract is for the supply of coated sachet vaccine baits designated as part number 128370, specifically formulated for oral rabies vaccination of wildlife populations. These baits are intended to be distributed in targeted areas to immunize terrestrial wildlife against rabies, leveraging a virus-vectored platform to ensure effective delivery and immune response. The product is a sachet formulation designed for environmental stability and animal acceptance, with coating mechanisms to protect the vaccine until consumed. The solicitation is categorized as a subcontract under NAICS code 325412, which pertains to pharmaceutical and biological product manufacturing, indicating the technical and regulatory rigor expected in production and quality control. Delivery and performance of the vaccine baits must occur within the designated place of performance in Concord, New Hampshire, with a response deadline set for September 7, 2026, and the opportunity posted on August 6, 2026. The contracting entity is the USDA’s Animal and Plant Health Inspection Service Wildlife Services division, reflecting the federal commitment to zoonotic disease control and wildlife health management.

POSTED

DEADLINE

in about 1 month

Proprietary Peritoneal Dialysis (PD) Supplies Supply and Delivery

247-NETWORK Contract Office 7 (36C247)

POSTED

DEADLINE

SUPPLY AND DELIVERY OF MEDICAL SUPPLIES

Solicitation # 19RP3826Q0059

The U.S. Department of State through the U.S. Embassy Manila is soliciting quotations for the supply and delivery of medical supplies under solicitation number 19RP3826Q0059, with a NAICS code of 325412. Offerors must submit their proposals electronically by August 10, 2026, at 4:00 p.m. Philippine local time, using MS-Word 2007/2010, MS-Excel 2007/2010, or Adobe Acrobat PDF formats, with individual files not exceeding 10MB; larger submissions must be split into multiple emails each under the size limit. Proposals must be in English and include the completed SF-1449 form, Section I Pricing, Section 5 Representations and Certifications, and any additional requirements outlined in Section 3 of the solicitation. All offerors must be registered in the System for Award Management (SAM) prior to submission, as mandated by FAR 4.1102, and failure to register will result in non-responsibility determination. Questions regarding the solicitation must be submitted in writing to ManilaContracting@state.gov no later than July 17, 2026, at 4:00 p.m. Philippine local time. The government intends to award a contract to the responsible vendor submitting the lowest priced acceptable offer, potentially holding discussions only if necessary. No details on delivery schedules, inspection criteria, packaging specifications, or evaluation factors are provided in the available documentation.

US Embassy Manila

POSTED

DEADLINE

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

Solicitation # HT9402-26-Q-9402

The Department of War, through the Defense Health Agency, is soliciting quotes under RFQ HT9402-26-Q-9402 to support the establishment and maintenance of the Uniform Formulary for the Military Health System, as mandated by 10 U.S.C. § 1074g and 32 CFR § 199.21. The process involves evaluating pharmaceutical agents for clinical and cost effectiveness to determine placement on the Uniform Formulary as generic, formulary, Basic Core Formulary, Extended Core Formulary, or non-formulary, with the goal of optimizing pharmaceutical procurement through Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements. Four newly approved drugs—Awiqli Flextouch (basal insulin), Cavhanza (BCR-ABL tyrosine kinase inhibitor for leukemia and lymphoma), Lipfendra (PCSK9 antilipidemic), and Trutakna (nephrology agent)—are scheduled for review at the November 2026 Pharmacy and Therapeutics Committee meeting, and industry responses will inform their inclusion or exclusion. Responses to the RFQ are due by August 27, 2026, with a pre-quotation teleconference scheduled for August 12, 2026, to clarify requirements. Clinical data submissions for evaluation must be sent via email to the designated point of contact by the deadline specified in Part 2.3.2. The solicitation, issued by the Defense Health Agency under NAICS code 325412, is managed from Aurora, Colorado, with performance centered in San Antonio, Texas. Primary contact is Julia Trang, with Stephanie Erpelding as secondary contact, and all submissions and inquiries must adhere to the instructions outlined in RFQ HT9402-26-Q-9402 to be considered valid.

Defense Health Agency

POSTED

DEADLINE

RABORAL VRG RACCOON BAITS, COATED SACHETS

Solicitation # 1171341

The U.S. Department of Agriculture, Animal and Plant Health Inspection Service (APHIS), through its Wildlife Services program, is seeking to procure up to 6,965,000 units of RABORAL V-RG® oral rabies vaccine baits under a firm fixed price IDIQ contract with a one-year period of performance, covering ordering from September 10, 2026, through September 30, 2027. The contract requires the delivery of two licensed bait types: the coated sachet (part number 128370) in a quantity of 6,915,000 units and the fishmeal polymer (part number 128425) in a quantity of 50,000 units, both manufactured by Boehringer-Ingelheim Animal Health USA, Inc. and containing a live recombinant vaccine that uses an attenuated Vaccinia virus to deliver the rabies glycoprotein gene, which is capable of inducing protective immunity in carnivore wildlife without causing rabies. In addition to bait delivery, the contractor must maintain a segregated, secure, and environmentally controlled storage facility at 115 Transtech Drive, Athens, Georgia, with the capacity to store up to four million baits at any time for no longer than 12 months, under strict temperature monitoring and pest control protocols, and in full compliance with all federal regulations for veterinary biological products. All shipments must be delivered FOB destination to CONUS locations designated at the time of order, with shipping costs included in the unit price. The contract imposes stringent technical and regulatory requirements, including proof of an active USDA CVB license, adherence to current Good Manufacturing Practices, validated cold chain logistics, and demonstrable surge capacity to respond to urgent rabies control needs. Evaluation is based on technical and regulatory compliance, manufacturing and supply chain quality, past performance on similar biological products, and price realism, with licensure serving as a mandatory pass/fail gate. Offers must be submitted by September 7, 2026, at 1700 ET to todd.k.bierl@usda.gov, cannot exceed 100 pages, and will not be accepted if late. The offeror must also comply with numerous federal representation and certification requirements, including those related to tax liability, inverted domestic corporations, drug trafficking, Buy American provisions, anti-discrimination laws, and DEI compliance, and certify that no subcontract

POSTED

DEADLINE

in about 1 month

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

Warranty & Technical Support ServicesThis contract entails the provision of one-year post-delivery technical support, troubleshooting, and warranty fulfillment services specifically for biotech reagents. The scope of work requires ongoing assistance to ensure the proper functionality and performance of the reagents after delivery, including resolution of technical issues, adherence to warranty terms, and responsiveness to user inquiries. Services must be delivered in alignment with industry standards for biotechnology products and meet the expectations of end users in research or diagnostic environments. The contract is classified as a subcontract under NAICS code 541715, which corresponds to research and development in the biomedical sciences. It is issued by the National Institutes of Health NIDA, part of the Department of Health and Human Services, and was posted on August 6, 2026, with a deadline for responses set for August 13, 2026. There is no specified set-aside designation, and the place of performance is not detailed in the provided data. All support activities must be completed within the one-year term following product delivery, with no indication of renewal options or extensions.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Small Business Set-Aside Compliance & OutreachThe contract supports a prime contractor in meeting small business participation goals through outreach, onboarding, and compliance reporting for DBE, MBE, and WBE entities. The scope includes actively engaging with diverse small businesses, facilitating their integration into project workflows, and ensuring all reporting requirements are accurately documented and submitted in alignment with federal compliance standards. This effort is critical to fulfilling contractual obligations related to minority- and women-owned business enterprise participation. The contract is classified as a subcontract under NAICS code 541611 and is associated with the National Institutes of Health NIDA, part of the Department of Health and Human Services. It was posted on August 6, 2026, with a response deadline of August 13, 2026. While specific performance location and point of contact details are not provided, the work is tied to federal procurement compliance and requires strict adherence to small business set-aside frameworks. Effective communication, documentation, and proactive engagement with certified businesses are essential to the successful execution of this subcontract.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Biotech Logistics and Cold Chain DistributionThe contract calls for specialized logistics services focused on the packaging, labeling, and shipment of temperature-sensitive biologic reagents requiring stringent cold chain protocols, including maintenance at -80°C throughout运输. The work involves rigorous compliance with controlled environmental standards to preserve sample integrity, ensuring that all handling, documentation, and transport adhere to industry-specific biologic shipment requirements. This subcontract is issued under the NAICS code 488190, which covers other support activities for air transportation, indicating a need for highly coordinated, specialized distribution beyond standard freight services. The National Institutes of Health, specifically NIDA under the Department of Health and Human Services, is the agency overseeing this procurement with a response deadline of August 13, 2026. While the exact place of performance is not specified, the nature of the work implies coordination across multiple facilities and potentially international points of delivery. Bidders must demonstrate proven experience in cold chain management for biologics, including validated packaging solutions, real-time temperature monitoring, contingency protocols for deviations, and compliance with regulatory expectations for biological material transport. All proposals must be submitted by the stated deadline to be considered for award.

Other Support Activities for Air Transportation

POSTED

DEADLINE

Custom Peptide Synthesis and Conjugation ServicesThe contract involves the synthesis of custom peptides and their conjugation to dextramer platforms labeled with fluorescent tags such as phycoerythrin (PE), specifically for use in immune monitoring applications. The work requires precise chemical synthesis of peptides tailored to specific immunological targets, followed by their stable attachment to dextramer scaffolds to enable high-sensitivity detection of antigen-specific T cells. Barcode labeling is a critical component, allowing multiplexed tracking and identification of multiple peptide-MHC complexes within a single sample, which enhances the efficiency and throughput of immune response analysis. The project is intended to support advanced research tools used in immunology and vaccine development, particularly in the context of infectious disease and cancer immunotherapy studies. This subcontract is issued under the National Institutes of Health NIDA, part of the Department of Health and Human Services, and falls under NAICS code 325414 for pharmaceutical preparation manufacturing. The opportunity was posted on August 6, 2026, with a response deadline of August 13, 2026. There is no set-aside designation specified, and no physical place of performance or point of contact details are provided. The work is expected to be performed by a qualified vendor capable of meeting high-purity standards and regulatory compliance for research-grade reagents, with deliverables including fully characterized peptide-dextramer-fluorophore conjugates ready for downstream immune cell assays.

Biological Product (except Diagnostic) Manufacturing

POSTED

DEADLINE

Repair and Installation services for the Heat Exchanger System on a Bruker 9.4 Tesla Magnetic Resonance Imaging (MRI) system

Solicitation # 75N98026Q00967

The National Institutes of Health, National Institute on Drug Abuse’s Intramural Research Program is conducting market research to identify qualified sources capable of providing emergency repair parts and installation services for the Triple-loop Heat Exchanger System on its Bruker 9.4 Tesla Magnetic Resonance Imaging scanner, which has failed and requires immediate replacement to prevent catastrophic magnet quenching. The requirement specifies a brand-name or equal heat exchanger that must interface seamlessly with the existing scanner software, building water supply, magnet cryomech, gradient, and shim coil cooling systems while ensuring stable cryomech operation and maintaining magnet pressure at 1040 mbar. All components must be new, unused, original equipment manufacturer parts authorized by Bruker Corporation, and installation must be performed exclusively by Bruker-certified technicians to preserve the MRI system’s existing warranty. The contractor must deliver and install the system within three months of order receipt, with a one-year warranty covering all parts, labor, travel, and including one preventative maintenance visit. Responses to this sources-sought notice must be submitted electronically by August 12, 2026, and must include detailed capability statements addressing each technical requirement separately, with supporting documentation on company size status under NAICS Code 334516, employee count, personnel qualifications, relevant government contracts, and complete contact and SAM.gov registration information including UEI and TIN. The notice explicitly states that no award will result from this action and that responses are not proposals or quotations. Companies must identify the place of manufacturing and confirm compliance with the Non-Manufacturer Rule if applicable. Proprietary or sensitive data should not be included, though any claimed proprietary information will be safeguarded. Responses are limited to ten pages excluding cover page and references, must reference solicitation number 75N98026Q00967SB, and be sent exclusively to Josh Lazarus at josh.lazarus@nih.gov. All respondents must have an active SAM.gov registration, and while small businesses are strongly encouraged to respond, the government retains full discretion on whether to pursue a competitive or non-competitive acquisition path based on the feedback received.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

dCODE Dextramer®

Solicitation # 75N98026Q00962SB

The National Institutes of Health, through the National Institute on Drug Abuse, is seeking information regarding the dCODE Dextramer® product under solicitation number 75N98026Q00962SB, with a response deadline of August 13, 2026 at 7:00 PM Eastern Time. This sources-sought notice, posted on August 6, 2026, aims to gather market capabilities and capabilities from potential suppliers to support research activities within the biomedical and life sciences domain, classified under NAICS code 334516 for medical and dental instruments and supplies. The solicitation is issued by the Office of the Director within the Department of Health and Human Services, located in Bethesda, Maryland, with no set-aside designation specified. Primary point of contact is Scott Duernberger, reachable at 301-594-0670 or scott.duernberger@nih.gov, with secondary support available from Kelly Dempsey. The place of performance has not been designated, and all responses must be submitted through the SAM.gov platform using the provided UI link.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE